Advertisement
Home Tags Prescription Drugs

Tag: Prescription Drugs

The benefits of ixekizumab in the treatment of psoriasis extend to 60 weeks

Ixekizumab Efficacious for Psoriasis Over 60 Weeks

0
Four in five patients saw at least a 75 percent improvement in symptoms
Proton pump inhibitor use is associated with increased risk of developing osteoporosis and osteopenia in femur bones

PPI Use Ups Risk of Osteoporosis, Osteopenia in Femur

0
PPI users have reduced mean femoral T-scores, increased frequency of osteoporosis, osteopenia
For mechanically ventilated intensive care unit patients

Clonidine Has Antipyretic Effect in ICU Patients

0
Patients receiving clonidine in addition to commonly used sedative agents have lower temperature
Overdoses from common anti-diarrhea drugs are being investigated by the U.S. Food and Drug Administration

FDA Warns of Overdoses of Anti-Diarrhea Drug

0
Loperamide can cause serious heart problems when taken in higher-than-recommended amounts
Sulfonylureas used as add-on therapy to metformin can maintain glycemic control in type 2 diabetes

No Significant Weight Change With Adjuvant Sulfonylureas

0
Addition maintains glycemic control without weight change among patients with T2DM taking metformin
Implementation of prescription drug monitoring programs can reduce the prescribing of Schedule II opioids

Prescription Drug Monitoring Programs Cut Opioid Use

0
Reduction in rate of prescribing of Schedule II opioids seen immediately after program launch
Daratumumab (Darzalex)

ASCO: Adding Daratumumab Early in Myeloma Treatment Efficacious

0
Response rate doubled for patients with relapsed or refractory multiple myeloma
Patients with advanced bladder cancer may benefit from the anti-PD-L1 immunotherapy atezolizumab (Tecentriq)

ASCO: Immunotherapy Beneficial in Advanced Bladder Cancer

0
About a quarter of older patients deemed too frail for chemo responded to atezolizumab
A novel antibody that targets claudin 18.2 is helping some patients with advanced gastric cancer live longer

ASCO: IMAB362 Can Lengthen Lives of Gastric Cancer Patients

0
Patients with advanced disease lived longer when they received this targeted treatment
For postmenopausal women with breast cancer

ASCO: Extension of Aromatase Inhibitor Tx Benefits Breast CA

0
Extension of aromatase inhibitor treatment to 10 years linked to higher rates of disease-free survival